SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus: into single digits

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (299)4/22/1998 3:40:00 PM
From: BDR  Read Replies (1) of 1016
 
<<First you list all the abstracts only citing studies funded
by vivus, then you say that at least the Sildenafil Study Group is honest enough to
site Pfizer as the source of their funds.>>

If you reread my post you will see that I attributed the Viagra studies to the Sildenafil Study Group (2 papers) and the Multicenter Study Group (1 paper). Those that came from the MUSE or MUSE/Actis study groups were also labelled. What exactly is it that you don't understand? Are you implying that, while the Sildenafil Study Group is funded by Pfizer, the MUSE Study Group is funded by an independent, non-profit foundation with no financial interest in Vivus?(g)

<<I see you are also a self promoted editor of
medical abstracts.>>

I don't see anyone else doing it. Anyone else who cares to can post information about the abstracts. When I quoted directly I used quotation marks, when I summarized or added an editorial comment I didn't. Obviously you are going to criticize anything I post so I suggest you skip my posts. I plan to do the same for yours.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext